Hypertension, often referred to as high blood pressure, is a major public health issue and a leading risk factor for cardiovascular diseases (CVDs) globally.
Dana-Farber Cancer Institute researchers have identified factors that determine whether donor lymphocyte infusion (DLI), a standard therapy for patients with acute myeloid leukemia (AML) who have ...